Cyberview Living Lab Accelerator 17th Cohort Registers More Than RM34 Million In Investment Interests Following Demo Day

Organised by Cyberview Sdn Bhd, startups and companies from the Cyberview Living Lab® Accelerator (CLLA) programme garnered a total potential investments value of more than RM34 million during the CLLA Cohort 17 Demo Day held on 21 November at RekaScape.

Working in Artificial Intelligence and Health Tech, the startups created innovative products and solutions poised to challenge existing norms and address consumers’ needs.

This year’s event started with presentations from CLLA’s Cohort 17, made up of Ever AI Technologies, ProSales, Mesolitica, FAVORIOT, LekirTech, Beebag, HappyPreggie and Smartoptz Technologies; startups focusing on developing digital solutions across various sectors, including property, retail and healthcare, to service businesses and consumers.

Cyberview Chief Executive Officer – Kamarul Ariffin Abdul Samad was proud to share that while undergoing the 5-month programme, these startups had a number of achievements, including forming 42 partnerships (with 42 more in the exploration stage), generating an average of more than 75% increase in cumulative revenue (since joining the CLLA programme) amounting to RM17.17 million and raised RM3.57 million in funds.

“Through the programme, they received a suite of benefits which included access to facilities, business advisory and mentorship, networking, as well as market access opportunities. More than 60 mentoring hours consisting of practical support and guidance from a diverse array of mentors, including seasoned venture capitalists, industry experts, serial entrepreneurs, and founders, along with insights from leading technologists and innovation strategists were conducted,” Kamarul Ariffin said.

Previous articleMaking A Climate-Conscious Effort To Drive Southeast Asia’s Data Centre Revolution
Next articleCIMB Bank Offers Account 2 Support Facility For EPF Members Via Cash Plus Personal Loan

LEAVE A REPLY

Please enter your comment!
Please enter your name here